Consolidated Evidence and New Frontiers of Liquid Biopsy in Lung Cancer: A Narrative Review
Ornella Cantale, Alessandro Nepote, Elisa Lombardi, Federica Benso, Tommaso Trisciuoglio, Angela Listì, Francesca Bersani, Riccardo Taulli, Luisella Righi, Francesco Passiglia · 2026
Read Consolidated Evidence and New Frontiers of Liquid Biopsy in Lung Cancer: A Narrative Review by Ornella Cantale, Alessandro Nepote, Elisa Lombardi, Federica Benso, Tommaso Trisciuoglio, Angela Listì, Francesca Bersani, Riccardo Taulli, Luisella Righi, Francesco Passiglia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13604926.txt.
Description
Ornella Cantale and a team of co-authors reviewed how blood-based tests, called liquid biopsies, are reshaping lung cancer care, in a 2026 narrative review. A tissue sample has long been the standard way to study a tumor, but it is invasive and can miss change over time. Blood tests can track tumor signals repeatedly and with less burden on the patient.
The team searched two large databases for work from 2017 to 2026 on both main lung cancer types. They weigh settled uses of the tests and newer ones still in development. Newer angles include pairing the tests with machine learning, joining them with multi-layer molecular data, and reading tumor signals from unusual body samples. The authors stress that standards and sensitivity still need work before some uses are ready for daily care.
Catalog record
| CREATOR | Ornella Cantale, Alessandro Nepote, Elisa Lombardi, Federica Benso, Tommaso Trisciuoglio, Angela Listì, Francesca Bersani, Riccardo Taulli, Luisella Righi, Francesco Passiglia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |